Cardinal Health stock: CVS distribution agreement extended through June 30, 2032

Cardinal Health said it signed a binding letter of intent to extend its pharmaceutical distribution agreements with CVS Health through June 30, 2032. The company reaffirmed its fiscal 2027 adjusted EPS guidance.

Cardinal Health said in an October 1, 2026 release that it entered into a binding letter of intent with CVS Health to extend its existing pharmaceutical distribution agreements through June 30, 2032. The company said the renewal reflects the continuation of its current scope of distribution services. Cardinal Health also reaffirmed its fiscal year 2027 non-GAAP diluted earnings-per-share guidance of 13% to 15% growth, or $12.40 to $12.60, and its long-term non-GAAP EPS growth guidance of 12% to 14%.

First-quarter results scheduled for November 5

Cardinal Health said it plans to release first-quarter fiscal 2027 results on November 5, 2026, before trading opens on the New York Stock Exchange. The company said its earnings discussion will begin at 8:30 a.m. Eastern. Cardinal Health said presentation slides and a webcast replay will be available through its Investor Relations page.